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Sarcoidosis Diagnosed After September 11, 2001, Among
Adults Exposed to the World Trade Center Disaster
Hannah T. Jordan, MD, Steven D. Stellman, PhD, David Prezant, MD, Alvin Teirstein, MD,
Sukhminder S. Osahan, PhD, and James E. Cone, MD
Objective: Explore relationships between World Trade Center (WTC) expo-
sures and sarcoidosis.Methods: Sarcoidosis has been reported after exposure
to the WTC disaster. We ascertained biopsy-proven post-9/11 sarcoidosis
among WTC Health Registry enrollees. Cases diagnosed after Registry en-
rollment were included in a nested case–control study. Controls were matched
to cases on age, sex, race or ethnicity, and eligibility group (eg, rescue or
recovery worker). Results: We identified 43 cases of post-9/11 sarcoidosis.
Twenty-eight incident cases and 109 controls were included in the case–
control analysis. Working on the WTC debris pile was associated with sar-
coidosis (odds ratio 9.1, 95% confidence interval 1.1 to 74.0), but WTC dust
cloud exposure was not (odds ratio 1.0, 95% confidence interval 0.4 to 2.8).
Conclusions: Working on the WTC debris pile was associated with an ele-
vated risk of post-9/11 sarcoidosis. Occupationally exposed workers may be
at increased risk.
S arcoidosis is a rare, multisystem granulomatous disease of un-known etiology that can involve any organ but most often affects
the lungs, skin, and/or eyes. A definitive diagnosis of sarcoidosis re-
quires identification of a characteristic pattern of immune cells (a
noncaseating granuloma) on a tissue biopsy and the exclusion of
infection and other illness with similar clinical presentations. Al-
though common symptoms include cough, shortness of breath, and
wheezing, a substantial proportion of persons with sarcoidosis are
asymptomatic. In such individuals, the disease is most often diag-
nosed after abnormalities are incidentally detected on chest radio-
graphs. Whether asymptomatic disease is recognized thus depends
upon the frequency with which diagnostic imaging is performed
in a particular population.1 Those with significant symptoms may
require treatment with corticosteroids or other immunosuppressive
medications. Approximately two thirds of persons with sarcoidosis
experience remission within a decade of diagnosis whereas the re-
maining one third develops progressive disease. Less than 5% of
those affected die because of sarcoidosis.2
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 Demonstrate familiarity with the diagnosis and treatment of
sarcoidosis, along with the environmental and occupational
exposures linked to this disease.
 Discuss the new findings on sarcoidosis and World Trade
Center (WTC) exposure.
 Identify specific factors associated with sarcoidosis risk
among people exposed to conditions at the WTC site.
Although the cause of sarcoidosis is unknown, a leading
hypothesis is that certain environmental exposures interact with
genetic factors to trigger an inflammatory response in suscepti-
ble individuals.3,4 This theory is supported by the occurrence of
sarcoidosis clusters among persons with shared work or home
environments5–7 and by observed associations between sarcoido-
sis and several environmental exposures including indoor exposure
to mold, mildew, musty odors, or wood-burning stoves.3,8,9 Several
exposures that may be encountered in occupational settings have
been implicated as potentially inciting agents, including microbial
bioaerosols, insecticides3, metals9, and inorganic particles.10
Firefighting is among the occupations that have been as-
sociated with sarcoidosis. An elevated incidence of sarcoidosis
was described among members of the Fire Department of New
York (FDNY) between 1985 and 1998,11 and a further increase
in sarcoidosis-like granulomatous pulmonary disease (SLGPD) was
observed during the first 5 years after the September 11, 2001, World
Trade Center (WTC) disaster (9/11) among FDNY members who
had performed postdisaster rescue or recovery work.12 Sarcoidosis-
like granulomatous pulmonary disease was also described among 38
rescue or recovery workers enrolled in the WTC Medical Monitor-
ing and Treatment Program,13 and among 23 lower-Manhattan area
residents, workers, and cleanup workers receiving medical care at
Bellevue Hospital,14 as well as in smaller case reports.15
These reports suggest a potential relationship between sar-
coidosis and 9/11-related exposures; however, there are only limited
epidemiologic data on the relationship between specific 9/11-related
exposures and sarcoidosis among rescue or recovery workers, and
even less for other exposed populations. We sought to describe post-
9/11 sarcoidosis in a diverse group of persons exposed to the disaster
and to examine associations between specific exposures and the de-
velopment of post-9/11 sarcoidosis.
MATERIALS AND METHODS
Data Collection
Our study population was the WTC Health Registry (the
Registry), a voluntary cohort formed to track the long-term
health of persons who were likely to have been highly exposed
to the events of 9/11. The Registry’s methods were described
previously.16–18 Lists of potentially eligible persons were obtained
from area employers and government agencies (list-identified
enrollees), and broad-based, multilingual media campaigns were
used to encourage potentially eligible persons to enroll via a
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toll-free telephone number or a Web site (self-identified enrollees).
Potential enrollees were recruited from the following groups:
rescue or recovery workers and volunteers, lower Manhattan
residents, lower Manhattan office workers, area school staff and
schoolchildren, and passersby on September 11. From September
2003 to November 2004, 71,437 persons completed a Wave 1 (W1)
enrollment questionnaire administered by computer-assisted tele-
phone interview (95%) or in-person interview (5%) after providing
informed consent. Wave 1 included questions on demographics,
exposures incurred during and after the 9/11 disaster, and health
information. Between November 2006 and January 2008, 46,322
enrollees completed the Wave 2 (W2) questionnaire (available at:
http://nyc.gov/html/doh/wtc/downloads/pdf/wtc/adult_survey2006-
2007.pdf) via mail (46%), Web site (42%), or computer-assisted
telephone interview (12%). Wave 2 included additional detailed
exposure questions and questions about mental and physical health,
including whether the respondent had ever been diagnosed with
sarcoidosis by a doctor or other health care professional.
Persons who reported a diagnosis of sarcoidosis on W2 were
mailed an in-depth sarcoidosis questionnaire (available from the au-
thors) and forms requesting permission to review medical records
and/or contact the respondent’s personal physician. The question-
naire inquired about symptoms, timing and method of diagnosis,
and functional status. Reminder telephone calls were attempted for
each eligible enrollee. We requested medical records and/or inter-
views with physicians for all consenting participants. Medical record
abstractions and physician interviews were conducted by New York
City (NYC) Department of Health and Mental Hygiene physicians.
The Centers for Disease Control and Prevention and NYC Health De-
partment institutional review boards approved the Registry protocol.
Case Definition
Cases were defined as sarcoidosis confirmed by demonstra-
tion of noncaseating granulomas and the absence of any known
granulomagenic organism or particle on a tissue biopsy performed
after October 2001 (verified by H.J. by medical record review or ver-
bal confirmation from the treating physician; subsamples of records
were independently reviewed by J.C. (n = 20), A.T. (n = 19), and
D.P. (n = 6); no disagreements among reviewers were identified).
Records were de-identified before review by A.T. or D.P. Enrollees
who did not report sarcoidosis on W2 and those determined not to
have diagnosis of sarcoidosis based on response to the sarcoidosis
questionnaire and/or medical record review were considered to have
no history of sarcoidosis. Enrollees who reported a history of sar-
coidosis on W2 but were diagnosed before November 2001, did not
have a definitive biopsy, or whose sarcoidosis could not be confirmed
medically were excluded.
Study Variables
We categorized enrollees into mutually exclusive and hier-
archical eligibility groups on the basis of likelihood of degree of
exposure, with rescue or recovery enrollees followed by lower Man-
hattan residents, lower Manhattan area workers, and passersby on
September 11. Exposures were defined on the basis of responses
to W1 and W2 questions. Dust cloud exposure was defined as be-
ing caught in the dust cloud on the morning of September 11 and
reporting a geocodable location in lower Manhattan17 or endors-
ing any of the following: could not see a couple of feet in front of
me; had trouble walking or finding my way because the dust was
so thick; had to find shelter such as under a car or in a doorway;
was covered from head to toe with dust or debris; or could not hear
anything.16 For rescue or recovery enrollees, exposure variables also
included duration of work (categorized as > or ≤55 days), arrival
time (arrival by vs after September 12), and whether work had been
performed on the debris pile resulting from the collapse of the WTC
and surrounding buildings. Among those who worked on the pile,
we examined the following specific tasks: firefighting, hand digging,
welding, and light construction. Respiratory protection was defined
as reporting the use of a full- or half-face respirator or disposable
mask with National Institute for Occupational Safety and Health’s
N95 to P100 rating during the period of arrival at the WTC site
(categorized as arrival on September 11, 2001; between September
12, 2001, and December 31, 2001; or after December 31, 2001).
Those who reported using no mask or a dust or surgical mask during
their arrival period were considered unprotected. Smoking status at
the time of the W1 survey was categorized as having ever or never
smoked. Self-reported physician-diagnosed asthma status and de-
mographic characteristics were obtained from the W1 or W2 survey.
Race or ethnicity was defined on the basis of the methods described
for the 2000 US Census.19 Sarcoidosis illness characteristics were
taken from the in-depth sarcoidosis survey, and clinical information
was obtained from medical records.
Data Analysis
Enrollees aged 18 years and older at the time of W1 who
also completed W2 were eligible for this analysis. We compared
demographic and exposure characteristics of case patients with those
of enrollees with no history of sarcoidosis using chi-square or Fisher
exact test. The Wilcoxon ranked sum test was used to compare
medians.
Confirmed cases diagnosed after an individual had enrolled
in the Registry were included in a nested case–control study; cases
diagnosed after 9/11 but before Registry enrollment (n = 15) were
excluded from the case–control analysis. Incidence-density sampling
was used to select up to four Registry controls with no history of sar-
coidosis for each case, individually matched on sex, race or ethnicity
(non-Hispanic white, non-Hispanic black, or Hispanic), eligibility
group(s), and age; for age, eligible controls for each respective case
were those who, during the study period, attained the age of the case
patient at the time of sarcoidosis diagnosis.20 Conditional logistic
regression was used to examine the relationship between post-9/11
sarcoidosis and 9/11-related exposures, smoking, study recruitment
source, and demographic factors. Separate models were created for
rescue or recovery enrollees and nonrescue or recovery enrollees.
Independent variables associated with sarcoidosis with a P ≤ 0.20
in bivariable analysis were entered into multivariable models. SAS
version 9.2 (SAS Institute Inc., Cary, NC) was used for all analyses.
P < 0.05 were considered significant.
RESULTS
Of 45,899 eligible Registry enrollees, 430 reported having
been diagnosed with sarcoidosis on the W2 screening question and
were mailed in-depth sarcoidosis surveys (Fig. 1). Of these, 265
(62%) responded, 158 (37%) refused or did not respond, and 7
(1%) had invalid addresses. Among respondents to the in-depth sur-
vey, 174 confirmed a history of sarcoidosis (80 before and 94 after
September 11, 2001), 17 reported an unclear history and/or timing
of diagnosis, and 74 denied having sarcoidosis. Permission to review
medical records and/or contact physicians was given by 84 (76%) of
the 111 participants who reported sarcoidosis diagnosed after 9/11
or at an unclear time or did not clearly state whether they had been
diagnosed with sarcoidosis. Records were obtained for 74, of which
43 met the definition of post-9/11 sarcoidosis. The remainder had ill-
nesses that were suggestive of sarcoidosis without a definitive biopsy
(n = 15), had no history of sarcoidosis in the medical record (n =
10), were diagnosed with sarcoidosis before September 11, 2001
(n = 5), or had a biopsy in October 2001 (n = 1).
Characteristics of Enrollees
With Post-9/11 Sarcoidosis
Table 1 shows demographic characteristics of enrollees
with and without post-9/11 sarcoidosis. Although there were no
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FIGURE 1. Ascertainment of post-9/11 sarcoidosis cases occurring among World Trade Center Health Registry enrollees.
statistically significant differences between the two groups, a higher
proportion of enrollees with post-9/11 sarcoidosis (86%) were self-
identified compared with persons with no history of sarcoidosis
(73%, P = 0.06).
Selected characteristics of enrollees with post-9/11 sarcoido-
sis are shown in Table 2. Although we identified fewer cases diag-
nosed in 2007 to 2008 compared to earlier years, W2 (the source of
case ascertainment) began in 2006, and 70% of Registry enrollees
who completed W2 did so in 2006 or within the first 3 months of
2007, and therefore did not have an opportunity to report diagnoses
made later. Most case patients (88%) reported having had at least one
sarcoidosis-related symptom. Among the 23 enrollees with cough, 17
(74%) reported exacerbation with exercise. Thirteen reported having
been diagnosed with asthma, six before 9/11, six after, and one at an
unspecified time. Only two had no evidence of intrathoracic disease.
Among the 19 persons with documented extrathoracic involvement,
the most common sites were the skin (n = 6), extrathoracic lymph
nodes (n = 6), liver (n = 3), and eye (n = 3). Nephrolithiasis was
reported in three cases, and central nervous system manifestations
were reported in two cases.
9/11 and Other Exposures
Of the 43 persons with confirmed post-9/11 sarcoidosis, 19
(44%) performed rescue or recovery work, 8 were NYC firefight-
ers, 2 were members of other fire departments, 4 were NYC Po-
lice Department employees, 3 worked for utility companies, 1 pro-
vided administration and support, and 1 worked for an unspecified
NYC agency. Eight of the workers arrived on 9/11, seven on 9/12,
one on 9/13, and three on 9/14; of the eight who arrived on 9/11,
five were caught in the dust cloud. Fifteen rescue or recovery en-
rollees reported working on the debris pile. The median duration
of work among rescue or recovery enrollees with sarcoidosis was
55 days (interquartile range, 5–98 days), compared with 19 days
(interquartile range, 5–52 days) for workers with no history of sar-
coidosis (P = 0.12).
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TABLE 1. Characteristics of Registry Enrollees With and Without Confirmed Post-9/11
Sarcoidosis*
No History of Sarcoidosis Post-9/11 Sarcoidosis
(N = 45,899) (N = 43)
Characteristic† N % N %
Sex
Male 28,080 61.2 29 67.4
Female 17,800 38.8 14 32.6
Age on September 11, 2001, yrs
<35 12,463 27.2 9 20.9
35–44 14,644 31.9 18 41.9
45 + 18,773 40.9 16 37.2
Race or ethnicity
Non-Hispanic white 31,945 69.6 28 65.1
Non-Hispanic black 4,638 10.1 6 14.0
Hispanic 5,227 11.4 9 20.9
Asian 2,545 5.6 0 0
Multiracial 844 1.8 0 0
Other 681 1.5 0 0
Eligibility group
Rescue and recovery workers and volunteers 21,414 46.7 19 44.2
Lower Manhattan residents 6,491 14.1 5 11.6
Lower Manhattan office workers 15,624 34.1 15 34.9
Passersby on September 11 2,266 4.9 4 9.3
Area school students or staff on September 11 85 0.2 0 0
Registry recruitment source
Identified by building or employer list 12,106 26.4 6 14.0
Self-referred to Registry 33,774 73.6 37 86.1
Residence on September 11, 2001
NYC 27,745 60.5 30 69.8
Outside NYC 18,135 39.5 13 30.2
Education
Non–high school graduate 1,672 3.7 1 2.3
High school or GED or up to 3 years of college 19,772 43.4 24 55.8
College graduate 14,743 32.3 14 32.6
Postgraduate degree 9,399 20.6 4 9.3
Total household income in 2002
<$50,000 11,850 28.6 11 26.8
$50,000–$74,999 9,013 21.8 14 34.2
≥$75,000 20,530 49.6 16 39.0
Smoking status at W1 survey
Never 25,829 56.6 29 67.4
Current or former 19,789 43.4 14 32.6
Exposure to dust cloud
Unexposed 24,142 54.7 19 47.5
Exposed 19,994 45.3 21 52.5
*No differences were statistically significant by chi-square or Fisher exact test.
†Counts may not sum to total because of missing values.
GED, general educational development.
The 24 nonrescue or recovery enrollees with post-9/11 sar-
coidosis were lower Manhattan residents (n = 5), area workers
(n = 15), or passersby on September 11, 2001 (n = 4). Fifteen
were exposed to the dust cloud, six reported that their workplaces
had been damaged by the disaster, three evacuated their homes, and
one reported his or her home being covered by a heavy layer of
dust.
Case–Control Study
Twenty-eight cases were eligible for inclusion in the case–
control analysis. Eleven of these were rescue or recovery enrollees,
11 were lower Manhattan area workers, 5 were area residents, and
1 was a passerby. Ten case patients were former smokers but none
smoked at the time of Registry enrollment. Exposures related to
9/11 and specific occupation at the time of 9/11 are shown for the
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TABLE 2. Characteristics of 43 World Trade Center Health Registry Enrollees With
Confirmed Post-9/11 Sarcoidosis
Characteristic N %
Age at diagnosis, yrs*
30–39 14 32.6
40–49 15 34.9














Chest CT or x-ray results†¶
Mediastinal or hilar adenopathy 27 62.7
Parenchymal abnormalities 7 16.3
Both 4 9.3
No abnormalities 2 4.7
Not available 3 7.0
Extrathoracic involvement†
Present 19 44.2
Reported as absent 4 9.3




Not mentioned in medical record 19 44.2
Self-reported symptoms (not mutually exclusive)
Fatigue 30 69.8
Shortness of breath 28 65.1
Chest tightness 24 55.8
Joint pain 24 55.8
Cough 23 53.5
Wheezing 21 48.8
Weight loss 16 37.2
Chest pain 15 34.9
Eye symptoms 15 34.9
Rash 11 25.6
Fever 7 16.3
Self-reported change in exercise tolerance due to sarcoidosis
Decreased tolerance for vigorous activities only 4 9.3
Decreased tolerance for moderate and vigorous activities 4 9.3
Decreased tolerance for light, moderate, and vigorous activities 5 11.6
No reported change 5 11.6
Missing 10 23.3
*Age at diagnosis missing for one individual.
†Information obtained from medical record review.
‡70% of Registry enrollees completed W2 before April 2007, and therefore did not have an opportunity to report
diagnoses made later in 2007 or in 2008.
§Individuals who had biopsies of the lung plus other tissues were categorized under lung biopsy.
||Other biopsy sites: cervical lymph nodes (4); liver (2); axillary lymph nodes (1); skin (1); supraclavicular and groin
lymph nodes (1); Kveim (1); unknown (1).
¶Parenchymal abnormalities: ground glass opacities, diffuse infiltrates, consolidation, nodules, and mosaic attenuation.
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NYC firefighter 09/11 98 X X X X X
NYC firefighter 09/11 6 X X X
NYC firefighter 09/12 23 X X X X
NYC firefighter 09/11 43 X X X X X
Firefighter
(non-NYC)
09/12 3 X X X
Firefighter
(non-NYC)
09/11 5 X X X
Utility company 09/11 210 X X X X
Utility company 09/14 143 X X X X X X X
NYC Police
Department







*Respiratory protection was defined as reporting the use of a full- or half-face respirator or a disposable mask with N95 to P100 rating during the period of arrival at the WTC
site (arrival on September 11, 2001, between September 12, 2001 and December 31, 2001, or after December 31, 2001).
rescue or recovery enrollees in Table 3. All of these case patients
arrived within 3 days after the disaster, and most worked on the
debris pile.
Table 4 shows odds ratios (ORs) for 9/11-related exposures
and risk of post-9/11 sarcoidosis for the 28 cases and 109 age-, sex-,
race/ethnicity-, and eligibility group-matched controls. One case was
matched to a single control; the remaining cases were matched to
four controls each. We did not find significant associations between
post-9/11 sarcoidosis and dust cloud exposure, or between post-
9/11 sarcoidosis and workplace or home damage among nonrescue
or recovery enrollees. Among rescue or recovery enrollees, work-
ing on the debris pile was significantly associated with sarcoidosis.
Specific tasks performed on the pile that were associated with sar-
coidosis were firefighting and hand digging. The conditional logistic
regression model for the relationship between post-9/11 sarcoidosis
and search and rescue did not converge because the risk set with
the single unexposed case did not contain any exposed controls;
however, the crude OR for hand digging was 13.5 (95% confidence
interval 1.6 to 117.1). Use of respiratory protection was not signif-
icantly associated with sarcoidosis. Multivariable models including
exposures associated with sarcoidosis in bivariable conditional logis-
tic regression were constructed, but the resulting ORs were neither
substantially altered, nor was model fit significantly improved.
DISCUSSION
Among rescue or recovery enrollees, who responded to the
9/11 disaster, working on the debris pile resulting from the collapse
of the WTC and nearby structures were associated with an elevated
risk of developing sarcoidosis. The specific tasks that were associated
with sarcoidosis (firefighting, hand digging, and search and rescue)
were performed by many of the same individuals, so each task’s
discrete contribution to the risk for sarcoidosis cannot be determined.
Instead, these activities collectively suggest that individuals who
executed the most complex, intensive rescue, and recovery activities
were at greatest risk. We did not identify risk factors for post-9/11
sarcoidosis among enrollees who did not perform rescue or recovery
work, perhaps because of low statistical power. It is also likely that
the greater intensity of exposure generally experienced by rescue
or recovery workers compared with other enrollees enabled us to
discern a relationship between 9/11 exposures and sarcoidosis in the
former group but not in the latter.
By comparing the study period for the report by Izbicki et al12
with the diagnosis dates for firefighters in our study, we estimate that
up to six of the 43 cases described in this article (up to three in the
case–control analysis) also may have been included in the report of
post-9/11 SLGPD among FDNY rescue workers. We repeated the
case–control analysis without the three potentially overlapping cases
and found no material changes in ORs relating to any task except
firefighting. Our results thus corroborate and extend the findings of
Izbicki et al by identifying risk factors for post-9/11 sarcoidosis and
describing cases among non-FDNY members. Whereas the eleva-
tion in post-9/11 SLGPD cases described by Izbicki et al occurred
primarily during the year after 9/11, our case–control study identi-
fied an association between sarcoidosis and 9/11-related exposures
even though cases included in this analysis were all diagnosed in
2003 or later. This suggests that the increased risk was not limited
to the years immediately after 9/11, underscoring the importance of
continued monitoring for sarcoidosis among exposed persons.
The 43 cases we identified represent the largest study of sar-
coidosis among persons exposed to 9/11 and one of the largest
groups of biopsy-proven sarcoidosis described in the medical lit-
erature. The clinical characteristics of these case patients are sim-
ilar to previous reports, including a case–control etiologic study
of sarcoidosis,21 a multicenter case–control study of 736 incident
cases of biopsy-proven sarcoidosis conducted in the United States
from 1997 to 1999. The peak age at diagnosis (40 to 49 years in
our study vs 35 to 45 years in a case–control etiologic study of
sarcoidosis), proportion with extrathoracic disease (44% vs 52%),
and proportion with disease limited to extrathoracic organs (5% vs
2%) were comparable.22,23 We did not have sufficient data to report
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TABLE 4. Odds Ratios for Post-9/11 Sarcoidosis Diagnosed After Enrollment in the World Trade Center
Health Registry*
Cases Controls
9/11-Related Exposures N % N % Odds ratio 95% CI P
All cases and controls†
Dust cloud exposure
Unexposed 11 42.3 40 41.2 ref 0.99
Exposed 15 57.7 57 58.8 1.0 0.4 2.8
Rescue or recovery enrollees†
Arrival time
9/11/2001 or 9/12/2001 9 81.8 26 60.5 2.9 0.6 14.7 0.21
After 9/12/2001 2 18.2 17 39.5 ref
Duration of work at site (days)
≤55 5 45.5 31 70.5 ref
>55 6 54.6 13 29.6 3.0 0.7 13.0 0.13
Worked on debris pile (at any time)
Yes 10 90.9 22 50.0 9.1 1.1 74.0 0.04
No 1 9.1 22 50.0 ref
Worked on pile 9/11 or 9/12
Yes 7 63.6 15 34.9 2.9 0.8 10.5 0.11
No 4 36.4 28 65.1 ref
Performed firefighting on pile
Yes 5 55.6 3 10.0 11.00 1.3 96.1 0.03
No 4 44.4 27 90.0 ref
Performed hand digging on pile
Yes 9 90.0 17 43.6 8.8 1.1 71.6 0.04
No 1 10.0 22 56.4 ref
Performed welding on pile
Yes 2 25.0 1 3.7 6.6 0.6 73.4 0.12
No 6 75.0 26 96.3 ref
Performed light construction on pile
Yes 2 22.2 4 12.9 2.1 0.3 12.7 0.44
No 7 77.8 27 87.1 ref
Nonrescue or recovery enrollees†
Workplace damage
Some 4 23.5 20 30.8 0.7 0.2 2.3 0.51
None 13 76.5 45 69.2 ref
Home damage
Some 1 5.9 6 9.2 0.6 0.1 6.2 0.67
None 16 94.1 59 90.8 ref
Abbreviation: CI, confidence interval.
*Cases and controls were matched on sex, age, race or ethnicity, and eligibility group(s). For age, eligible controls for each respective case were
those whose age at study enrollment was less than or equal to the case-patient’s age at the time of sarcoidosis diagnosis and whose age at W1 was more
than or equal to the case-patient’s age at the time of sarcoidosis diagnosis. Odds ratios were calculated using conditional logistic regression.
†For full case–control study, n = 28 cases, 109 controls; among rescue or recovery enrollees, n = 11 cases, 44 controls; and among nonrescue or
recovery enrollees, n = 17 cases, 65 controls. Cell counts may not sum to total because of missing values.
pulmonary function testing results, but a high proportion of case
patients reported symptoms suggestive of asthma such as wheezing
(49%); this is similar to the proportion with asthma-like symptoms
among FDNY workers with SLGPD (58%) and the proportion with
wheezing in the Bellevue Hospital case series (52%), and on the
high end of airway hyperreactivity rates reported in other studies of
sarcoidosis (21% to 50%), suggesting that persons with post-9/11
sarcoidosis may be particularly likely to benefit from treatment of
airway hyperreactivity.24–28
The incidence of sarcoidosis in NYC is unknown, so we could
not determine whether the number of cases observed during our study
period exceeded the number that would have been expected in our
cohort had 9/11 not occurred. Furthermore, given previous reports of
sarcoidosis among 9/11 survivors and the availability of WTC health
monitoring and treatment programs, 9/11-exposed persons may be
more likely to receive screening chest x-rays than the general public,
creating the potential for detection bias that could spuriously elevate
the ratio of observed to expected cases. Both cases and controls
in our study are likely to have been subject to increased scrutiny
for sarcoidosis compared with the general public, but this potential
detection bias would not be expected to differ between cases and
controls.
Because objective measurements of 9/11-related exposures
are not available, we relied upon self-reported exposure data.
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Although such data are subject to recall decay, they were gathered at
study enrollment before cases included in the case–control analysis
were diagnosed, decreasing the potential for differential misclas-
sification of exposure. Because of a stringent case definition that
could be confirmed only if we were granted permission to review
medical records, our study is likely to have been limited by under-
ascertainment of sarcoidosis cases and thus diminished statistical
power. Because sarcoidosis is a diagnosis of exclusion; however,
a rigorous case definition was required to ensure that our findings
accurately reflect the clinical and epidemiologic features of post-
9/11 sarcoidosis. Conversely, it is possible that ill persons were more
likely to join the Registry than well persons, and that the Registry
therefore overrepresents the proportion of 9/11-exposed persons who
subsequently developed sarcoidosis. We attempted to minimize the
potential for self-selection bias by restricting the case–control study
to persons diagnosed with sarcoidosis after study enrollment, and
by examining the relationship between study recruitment source and
sarcoidosis. Although we reviewed medical records or contacted
treating physicians for all included cases, the quality of available
records varied, resulting in limited clinical information, including
severity and course of disease. We also lacked information on family
history of sarcoidosis and occupational and recreational exposures
that have been associated with sarcoidosis in previous studies.
Despite these limitations, our study provides insight into the
risk factors for and clinical presentation of sarcoidosis among per-
sons exposed to 9/11, as well as sarcoidosis in general. The associa-
tions identified between post-9/11 sarcoidosis and specific activities
performed on the debris pile substantiate the association between
occupational exposures and sarcoidosis. Our results suggest that the
yet-unidentified causative agent(s) may have been inhaled or ab-
sorbed during activities involving intense exposure to WTC dust and
debris, strengthening the rationale for providing adequate respira-
tory and mucous membrane protection and improving engineering
controls for dust suppression after future disasters.
CONCLUSIONS
Our results suggest that clinicians who care for people who
were exposed to the events of 9/11 should be aware of the asso-
ciation between intensive rescue and recovery work and post-9/11
sarcoidosis, and that the elevated risk of sarcoidosis was not limited
to the year immediately after the disaster. Several questions, includ-
ing whether the risk of post-9/11 sarcoidosis extended to nonrescue
and recovery workers, remain unanswered. It will be crucial to gather
such information through continued monitoring of the health of per-
sons exposed to the events of 9/11. Meanwhile, our findings may
guide health monitoring after future urban disasters and may inform
studies of potential causative agents for sarcoidosis.
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